BMI与年龄对辅助生殖技术结局的联合影响
该多中心回顾性队列研究纳入14 213例首次IVF/ICSI周期患者,评估女性年龄与BMI对累积活产率(CLBR)的联合影响。超重(aOR 0.86,95%CI 0.77-0.96)和肥胖(aOR 0.74,95%CI 0.62-0.87)较正常体重CLBR降低。作者认为延迟IVF以减重需考虑年龄,尤其38岁以上女性仅在短期(3个月)大幅减重可能获益。
要点
- 超重和肥胖较正常体重CLBR降低,aOR分别为0.86和0.74。
- 1年内减重对35岁以下女性可能有益,36-38岁仅大幅减重可能有益。
- 38岁以上女性1年内即使大幅减重也不能抵消年龄影响,但短期可能有益。
核心结论
- 作者认为,关于延迟IVF以优化女性体重的建议应考虑女性年龄,尤其38岁以上女性仅在短期(3个月)大幅减重才似乎提供任何益处。
研究设计与样本
- 多中心回顾性队列研究,纳入2013年1月至2018年2月间18个跨国私立生育诊所中心首次IVF/ICSI周期并后续胚胎移植的患者14 213例,使用自体卵母细胞。
- BMI分为低体重(<18.5 kg/m2)、正常体重(18.5-24.9 kg/m2)、超重(25.0-29.9 kg/m2)和肥胖(≥30.0 kg/m2)。
- 主要结局为累积活产率(CLBR),次要结局为妊娠时间。
- 建立两个多变量回归模型:模型1将BMI作为有序分类变量,以1年时间段估计CLBR;模型2将BMI作为连续变量使用最佳拟合分数多项式,以3个月较短时间框架估计CLBR。
主要发现
- 与正常体重相比,超重女性CLBR较低(aOR 0.86,95%CI 0.77-0.96),肥胖女性CLBR较低(aOR 0.74,95%CI 0.62-0.87)。
- 1年内BMI降低,从肥胖降至超重或从超重降至正常体重,在35岁及以下可能有益;36-38岁女性仅大幅降低(即从肥胖降至正常BMI)可能有益。
- 38岁以上女性,1年跨度内即使相当程度减重也不能抵消年龄的影响,但在较短时间框架内可能有益。
- 3个月时间框架内,33.25岁及以下女性BMI降低1 kg/m2、33.50-35.50岁女性降低2 kg/m2,CLBR可能有潜在益处。
- 年龄更大的女性需要更大幅度的减重才能获得临床益处:35.75-37.25岁女性需3 kg/m2,37.50-39.00岁女性需4 kg/m2,39.25岁以上女性需5 kg/m2或更多。
关键数值与推荐
- 超重 vs 正常体重:aOR 0.86(95%CI 0.77-0.96)。
- 肥胖 vs 正常体重:aOR 0.74(95%CI 0.62-0.87)。
- 3个月时间框架内,33.25岁及以下女性BMI降低1 kg/m2可能有益;33.50-35.50岁女性降低2 kg/m2可能有益。
- 3个月时间框架内,35.75-37.25岁女性需降低3 kg/m2、37.50-39.00岁女性需降低4 kg/m2、39.25岁以上女性需降低5 kg/m2或更多才可能获得临床益处。
临床怎么用
- 作者认为,在ART前1年内采取减重策略可能有潜在益处,尤其对35岁以下且BMI≥25 kg/m2的女性。
- 作者认为,对于35岁以上女性,减重应大幅或发生在更短时间框架内,以避免女性年龄增长对CLBR的负面影响。
- 作者认为,根据年龄制定个体化减重方案可能是最佳行动方案。
局限性
- 该研究受限于回顾性设计。
- 极端BMI类别中女性数量较少。
- 未评估个体减重对患者结局的实际效果,因为这是回顾性患者间比较,用以估计固定时间段内减重和衰老对CLBR的联合效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: For a woman with infertility and overweight/obesity, can infertility treatment be postponed to first promote weight loss? SUMMARY ANSWER: Advice regarding a delay in IVF treatment to optimize female weight should consider female age, particularly in women over 38 years for whom only substantial weight loss in a short period of time (3 months) seems to provide any benefit. WHAT IS KNOWN ALREADY: Body weight excess and advanced age are both common findings in infertile patients, creating the dilemma of whether to promote weight loss first or proceed to fertility treatment immediately. Despite their known impact on fertility, studies assessing the combined effect of female age and BMI on cumulative live birth rates (CLBRs) are still scarce and conflicting. STUDY DESIGN, SIZE, DURATION: We performed a multicentre retrospective cohort study including 14 213 patients undergoing their first IVF/ICSI cycle with autologous oocytes and subsequent embryo transfers, between January 2013 and February 2018 in 18 centres of a multinational private fertility clinic. BMI was subdivided into the following subgroups: underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and obesity (≥30.0 kg/m2). PARTICIPANTS/MATERIALS, SETTING, METHODS: The primary outcome was CLBR. The secondary outcome was time to pregnancy. To assess the influence of female age and BMI on CLBR, two multivariable regression models were developed with BMI being added in the models as either an ordinal categorical variable (Model 1) or a continuous variable (Model 2) using the best-fitting fractional polynomials. CLBR was estimated over 1-year periods (Model 1) and shorter timeframes of 3 months (Model 2). We then compared the predicted CLBRs according to BMI and age. MAIN RESULTS AND THE ROLE OF CHANCE: When compared to normal weight, CLBRs were lower in women who were overweight (adjusted odds ratio (aOR) 0.86, 95% CI 0.77-0.96) and obese (aOR 0.74, 95% CI 0.62-0.87). A reduction of BMI within 1 year, from obesity to overweight or overweight to normal weight would be potentially beneficial up to 35 years old, while only a substantial reduction (i.e. from obesity to normal BMI) would be potentially beneficial in women aged 36-38 years. Above 38 years of age, even considerable weight loss did not compensate for the effect of age over a 1-year span but may be beneficial in shorter time frames. In a timeframe of 3 months, there is a potential benefit in CLBR if there is a loss of 1 kg/m2 in BMI for women up to 33.25 years and 2 kg/m2 in women aged 33.50-35.50 years. Older women would require more challenging weight loss to achieve clinical benefit, specifically 3 kg/m2 in women aged 35.75-37.25 years old, 4 kg/m2 in women aged 37.50-39.00 years old, and 5 kg/m2 or more in women over 39.25 years old. LIMITATIONS, REASONS FOR CAUTION: This study is limited by its retrospective design and lower number of women in the extreme BMI categories. The actual effect of individual weight loss on patient outcomes was also not evaluated, as this was a retrospective interpatient comparison to estimate the combined effect of weight loss and ageing in a fixed period on CLBR. WIDER IMPLICATIONS OF THE FINDINGS: Our findings suggest that there is potential benefit in weight loss strategies within 1 year prior to ART, particularly in women under 35 years with BMI ≥25 kg/m2. For those over 35 years of age, weight loss should be considerable or occur in a shorter timeframe to avoid the negative effect of advancing female age on CLBR. A tailored approach for weight loss, according to age, might be the best course of action. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was obtained for this study. All authors have no conflicts to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Rafael F, Rodrigues MD, Bellver J, et al. The combined effect of BMI and age on ART outcomes. Hum Reprod. 2023. PMID: 36928306. doi:10.1093/humrep/dead042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。